UnitedHealthcare
Esbriet (pirfenidone)
Drugs for the Lungs : Drugs for the Lungs
  • Idiopathic Pulmonary Fibrosis (IPF):
    Duration: 12 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Specialist Type(s): Pulmonologist
    Reauthorization Required: Yes
    Duration of Reauthorization: = 12 month(s)
    Policy requires patient to be non-smoker: No
    Evidence required for non-smoker: No
    FVC % Value in Policy: N/A
    Carbon Monoxide Diffusion Capacity (DLCO): N/A
    Patient Must Not Have End Stage Renal Disease (ESRD) or Severe Hepatic Impairment: No
    Reapproval criteria includes that the patient has less than 10% decrease in FVC: No
    ESRD or severe hepatic impairment criteria: No

  • Quantity Limit: limit maximum 9 EA PER 1 day(s)
  • Prior Authorization: Idiopathic Pulmonary Fibrosis (IPF):
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Duration: 12 Month(s)
    Reauthorization Required: Yes